Related references
Note: Only part of the references are listed.How I treat HHV8/KSHV-related diseases in posttransplant patients
Giovanni Riva et al.
BLOOD (2012)
Detection of human herpesvirus 8 by quantitative polymerase chain reaction: development and standardisation of methods
David J. Speicher et al.
BMC INFECTIOUS DISEASES (2012)
Castleman disease in a pediatric liver transplant recipient: A case report and literature review
Hugo J. R. Bonatti et al.
PEDIATRIC TRANSPLANTATION (2012)
Post-Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosuppression
E. J. Lim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2011)
Herpes Viruses in Transplant Recipients: HSV, VZV, Human Herpes Viruses, and EBV
Kevin Shiley et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Reply to the letter by Law et al. Is Rituximab therapy in Castleman's disease a risk factor for Kaposi sarcoma reactivation?
Paolo Nicoli et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Castleman's disease-a two compartment model of HHV8 infection
Klaus-Martin Schulte et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Castleman Disease An Update on Classification and the Spectrum of Associated Lesions
Danielle M. P. Cronin et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Lucie Kalinova et al.
BIOMEDICAL PAPERS-OLOMOUC (2009)
Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide
Georg Stary et al.
AIDS (2008)
HIV-associated multicentric Castleman's disease
Justin Stebbing et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
False-Negative Results in Nucleic Acid Amplification Tests—Do We Need to Routinely Use Two Genetic Targets in all Assays to Overcome Problems Caused by Sequence Variation?
D. M. Whiley et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2008)
Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial
Corey Casper et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Brief communication: Rituximab in HIV-associated multicentric Castleman disease
Mark Bower et al.
ANNALS OF INTERNAL MEDICINE (2007)
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus-associated multicentric Castleman's disease:: ANRS 117 CastlemaB trial
Laurence Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Concomitant and fatal HHV-8+ multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV- liver transplant patient
S. Gaitonde et al.
HISTOPATHOLOGY (2007)
Kaposi's sarcoma in transplant and HIV-infected patients: An epidemiologic study in Italy and France
D Serraino et al.
TRANSPLANTATION (2005)
The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care
C Casper
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Rituximab therapy for HIV-associated Castleman disease
AG Marcelin et al.
BLOOD (2003)
Multicentric Castleman's disease treated with antivirals and immunosuppressants
S Senanayake et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Molecular epidemiology of human herpesvirus 8 in Africa:: Both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespread
V Lacoste et al.
VIROLOGY (2000)
Share Paper
